Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer Marcus BeckDirk Böhmerthe Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party Radiation Oncology of the German Cancer Society (DKG-ARO) Original Article 29 November 2019 Pages: 109 - 116
Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients Khaled ElsayadGabriele ReinartzHans Theodor Eich Original Article 15 November 2019 Pages: 117 - 125
De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma Michael OertelKhaled ElsayadHans Theodor Eich Original Article 22 November 2019 Pages: 126 - 131
Dose escalation in radiotherapy for incomplete transarterial chemoembolization of hepatocellular carcinoma Hwa Kyung ByunHyun Ju KimJinsil Seong Original Article 08 July 2019 Pages: 132 - 141
Pulmonary function changes following helical tomotherapy in patients with inoperable, locally advanced non-small cell lung cancer K. VekensS. VerbanckE. Vanderhelst Original Article 12 July 2019 Pages: 142 - 150
Image-based lung functional radiotherapy planning for non-small cell lung cancer Faegheh S. MounessiJörg EckardtStefan Könemann Original Article 02 October 2019 Pages: 151 - 158
Tumor regression during radiotherapy for non-small cell lung cancer patients using cone-beam computed tomography images J. E. van TimmerenW. van ElmptC. Brink Original Article Open access 26 September 2019 Pages: 159 - 171
Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studies Xiao HuBing XiaMing Chen Original Article 29 November 2019 Pages: 172 - 181
A novel approach to SBRT patient quality assurance using EPID-based real-time transit dosimetry Christos MoustakisFatemeh Ebrahimi TazehmahallehSergiu Scobioala Original Article 10 January 2020 Pages: 182 - 192
Publisher Correction to: Heparin treatment mitigates radiation-induced oral mucositis in mice by interplaying with repopulation processes Springer Berlin Heidelberg Publisher Correction Open access 23 December 2019 Pages: 193 - 193
Neoadjuvante Radiotherapie verbessert beim resezierbaren hepatozellulären Karzinom mit Portalvenen-Tumorthrombus das Gesamtüberleben und das krankheitsfreie Intervall Thomas B. BrunnerRoland S. Croner Literatur kommentiert 23 December 2019 Pages: 194 - 196
Radiotherapie mit Cetuximab oder Cisplatin beim Plattenepithelkarzinom der Kopf-Hals-Region – was ist zu bevorzugen? Jens von der GrünPanagiotis Balermpas Literatur kommentiert 23 December 2019 Pages: 197 - 199
FDG-PET/CT zum Ausschluss von zervikalen Lymphknotenmetastasen bei Kopf-Hals-Tumoren in der klinischen N0-Situation Stefan WelzD. Zips Literatur kommentiert Open access 14 January 2020 Pages: 200 - 201
Radiotherapie versus transorale roboterassistierte Chirurgie in der Primärtherapie des Oropharynxkarzinoms: Randomisierung entscheidet Alexander FabianDavid Krug Literatur kommentiert 12 December 2019 Pages: 202 - 204